David L Paterson, MD
University of Pittsburgh
10
10
7
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (10)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Fernanda Silveira, MD
University of Pittsburgh
Shared therapeutic areas:
Worked with same sponsors:
Seetha Shankaran, MD
Wayne State University
Shared therapeutic areas:
Dale L. Phelps, MD
University of Rochester
Shared therapeutic areas:
Neil N. Finer, MD
University of California, San Diego
Shared therapeutic areas:
Richard A. Ehrenkranz, MD
Yale University
Shared therapeutic areas:
T. Michael O'Shea, MD MPH
Wake Forest University
Shared therapeutic areas:
Abbot R. Laptook, MD
Brown University, Women & Infants Hospital of Rhode Island
Shared therapeutic areas:
Waldemar A. Carlo, MD
University of Alabama at Birmingham
Shared therapeutic areas:
Krisa P. Van Meurs, MD
Stanford University
Shared therapeutic areas:
Abhik Das, PhD
RTI International
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (10)
Showing 10 of 10 trials
Quinolone Resistance in Bloodstream Isolates of Escherichia Coli
Changing Patterns of Candida Infections in Urban Medical Centers
Towards Reducing Resistance and Hematological Toxicity of Linezolid
Pharmacodynamic Parameters of Two Different Doses of Cefepime
Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients
Microbiologic Effect of Selective Decontamination of the Digestive Tract With Colistin, Gentamicin and Nystatin
WP16302 A Bioequivalence Study Comparing Ganciclovir From the Valganciclovir Syrup Formulation and the Commercial Valganciclovir 450mg Tablet (Valcyte®) at a Dose of 900mg in Kidney Transplant Recipients
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
All 10 trials loaded